Insider Insights
04.05.2022
The European Health Data Space launch

The EHDS will integrate three main product markets for primary use of health data: electronic health...

Read more
Insider Insights
04.05.2022
UK second lowest across major health outcomes

The data is derived from the Organisation for Economic Co-operation and Development (OECD) Health St...

Read more
Insider Insights
04.05.2022
CNAM spending on medicines 11.1% in 2022

Spending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicin...

Read more
Insider Insights
29.04.2022
EUCOPE anticipates OMP Regulation review

EUCOPE notes that “while these proposals don’t necessarily represent the final options included ...

Read more
Insider Insights
27.04.2022
Optimised NICE recommendations

According to the ABPI, over the last 20 years, 82% of technology appraisal recommendations have been...

Read more
Insider Insights
26.04.2022
List of similar biological groups

Legislation published in the Journal Officiel on 14th April 2022 establishes a first list of similar...

Read more
Insider Insights
21.04.2022
Innovation and affordability of orphan drugs

The paper examines potential reforms to current policies and practices related to orphan drug develo...

Read more
Insider Insights
20.04.2022
Access to cancer drugs

According to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...

Read more
Insider Insights
19.04.2022
Payment model to be launched for antibiotics

The UK looks set to become the first country in the world to use a subscription-style payment model ...

Read more
Insider Insights
14.04.2022
Latest survey shows disparities in access

The study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.